Federal Register / Vol. 61, No. 119 / Wednesday, June 19, 1996 / Notices 31117

1Copies of the Modifying Order are available

from the Commission’s Public Reference Branch,

H–130, 6th Street and Pennsylvania Avenue, N.W.,

Washington, D.C. 20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 6th Street & Pennsylvania

Avenue, N.W., Washington, D.C. 20580.

1Copies of the Consent Order, Set Aside Order

and Commissioner Starek’s statement are available

from the Commission’s Public Reference Branch,

H–130, 6th Street and Pennsylvania Avenue, N.W.,

Washington, D.C. 20580.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Federal Reserve Bank and Branch

director appointments.

2. Personnel actions (appointments,

promotions, assignments, reassignments, and

salary actions) involving individual Federal

Reserve System employees.

3. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Mr. Joseph R. Coyne, Assistant to the

Board; (202) 452–3204. You may call

(202) 452–3207, beginning at

approximately 5 p.m. two business days

before this meeting, for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting.

Dated: June 14, 1996.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 96–15715 Filed 6–17–96; 8:45 am]

BILLING CODE 6210–01–P

FEDERAL TRADE COMMISSION

[Dkt. C–3238]

American Stores Company, et al.;

Prohibited Trade Practices and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission

ACTION: Modifying order

SUMMARY: This order reopens a 1988

consent order that required American

Stores to divest certain retail grocery

stores in parts of California and Nevada

and to obtain Commission approval

before acquiring certain grocery stores.

This order modifies the consent order

by deleting the prior-approval

requirements in Paragraph VIII of the

consent order pursuant to the

Commission’s Prior Approval Policy—

under which the Commission presumes

that the public interest requires

reopening and setting aside the priorapproval provisions in outstanding

merger orders, making them consistent

with the policy—and by replacing that

provision with a prior notification

provision.

DATES: Consent order issued August 31,

1988. Modifying order issued December

1, 1995.1

FOR FURTHER INFORMATION CONTACT:

Roberta Baruch, FTC/S–2115,

Washington, D.C. 20580. (202) 326–

2861.

SUPPLEMENTARY INFORMATION: In the

Matter of American Stores Company, et

al. The prohibited trade practices and/

or corrective actions are changed, in

part, as indicated in the summary.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Donald S. Clark,

Secretary.

[FR Doc. 96–15483 Filed 6–18–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–3637]

BBDO Worldwide, Inc.; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order prohibits, among other

things, a New York advertising firm

from misrepresenting the amount of fat,

calories, or cholesterol in any frozen

yogurt, any frozen sorbet, and most ice

cream products. This action stems from

the firm’s role in developing certain

advertisements for Haagen-Dazs frozen

yogurt products.

DATES: Complaint and Order issued

January 24, 1996.1

FOR FURTHER INFORMATION CONTACT:

Anne Maher, FTC/S–4002, Washington,

D.C. 20580. (202) 326–2987.

SUPPLEMENTARY INFORMATION: On Friday,

October 27, 1995, there was published

in the Federal Register, 60 FR 55031, a

proposed consent agreement with

analysis In the Matter of BBDO

Worldwide, Inc., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to cease and desist, as set forth

in the proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45, 52)

Donald S. Clark,

Secretary.

[FR Doc. 96–15484 Filed 6–18–96; 8:45 am]

BILLING CODE 6750–01–M

[Dkt. C–2967]

California Medical Association;

Prohibited Trade Practices and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Set Aside Order.

SUMMARY: This order reopens a 1979

consent order, which prohibited the

medical association from participating

in the creation or dissemination of fee

schedules relating to physician

compensation, and sets aside the

consent order pursuant to the

Commission’s determination that the

public interest requires reopening and

setting aside the order because the order

presents an obstacle to the respondent

forming and operating a managed care

subsidiary.

DATES: Consent order issued April 17,

1979. Set aside order issued October 27,

1995.1

FOR FURTHER INFORMATION CONTACT:

Roberta Baruch, FTC/S–2115,

Washington, D.C. 20580. (202) 326–

2861.

SUPPLEMENTARY INFORMATION: In the

Matter of California Medical

Association. The prohibited trade

practices and/or corrective actions are

removed as indicated.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45)

Donald S. Clark,

Secretary.

[FR Doc. 96–15485 Filed 6–18–96; 8:45 am]

BILLING CODE 6750–01–M

[Docket No. C–3594]

Eli Lilly and Company, Inc.,; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, and Indiana producer of

pharmaceutical products to: ensure that

the acquired company, PCS Health

Systems (PCS), maintains an open

formulary; appoint an independent

Pharmacy and Therapeutics (P&T)

Committee of health care professionals

to objectively evaluate drugs for